Establishment of High Throughput SARS-CoV-2 Binding Antibody Immunoassay Capability and Testing of Human Serum Samples

Award Notice Posted

Solicitation number
75A50120R00036
Agency
Awarded
to PPD Development LP
Set-aside
No set-aside

Opportunity facts

Contract number
75A50121P00004 Federal contract award
Place of performance
Richmond VA 23230 USA

Notice details come from SAM.gov. Updated .

About this opportunity

This Award Notice from the Department of Health and Human Services establishes a contract with PPD Development, L.P. to provide high throughput multiplex MSD-ECL immunoassay services for COVID-19. The contractor will establish an assay for use in testing human serum samples from COVID-19 vaccine clinical trials in compliance with GCLP. The contractor will also provide serologic data to support establishing a correlate of protection to help facilitate expanded use and accelerated approval of additional COVID-19 vaccines. The awarded fixed price contract totals $128,309,470 for unspecified quantities or timelines.

Notice text

The objectives of this contract are: (1) Contractor to establish a high throughput multiplex MSD-ECL immunoassay for COVID-19 for use in testing of serum samples from human subjects enrolled in clinical trials of COVID-19 vaccines in compliance with Good Clinical Laboratory Practice (GCLP); and (2) Contractor to provide the USG with serologic data to support establishment of a correlate of protection to help facilitate expanded use of approved COVID-19 vaccines and accelerated approvals of additional vaccines.

Awarded contract 75A50121P00004 to PPD DEVELOPMENT, L.P. for 12830947.00 on 2020-11-17.

Files

File Type Posted
Class J and A Final 3.21.20.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors